Similar articles

• Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.

  Kooh SW, Fraser D, DeLuca HF, Holick MF, Belsey RE, Clark MB, Murray TM. Kooh SW, et al. N Engl J Med. 1975 Oct 23;293(17):840-4. doi: 10.1056/NEJM197510232931702. N Engl J Med. 1975. PMID: 170516
• Biotransformations of 25-hydroxyvitamin D3 by kidney microsomes.

  Gray RW, Caldas AE, Weber JL, Ghazarian JG. Gray RW, et al. Biochem Biophys Res Commun. 1978 May 15;82(1):212-8. doi: 10.1016/0006-291x(78)90585-5. Biochem Biophys Res Commun. 1978. PMID: 208553 No abstract available.
• [Biological activities of vitamin D3 metabolites and their new analogs (author's transl)].

  Ikekawa N. Ikekawa N. Horumon To Rinsho. 1981 Nov;29(11):1363-71. Horumon To Rinsho. 1981. PMID: 6280907 Japanese. No abstract available.
• Vitamin D. Metabolism and mechanism of action.

  Olson EB Jr, DeLuca HF. Olson EB Jr, et al. World Rev Nutr Diet. 1973;17:164-88. World Rev Nutr Diet. 1973. PMID: 4348597 Review. No abstract available.
• The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.

  Voigts AL, Felsenfeld AJ, Llach F. Voigts AL, et al. Arch Intern Med. 1983 Jun;143(6):1205-11. Arch Intern Med. 1983. PMID: 6344827 Review.